Challenge Application
i2.JP is currently recruiting ideas from individuals and teams who are interested in tackling the following themes. If you are interested, please check the outline and eligibility before sending in your application. We are looking forward to hearing from you. Please feel free to contact us if you have any questions about Challenge Application.
Early diagnosis for CKD
We are seeking for innovative healthcare products or services to support early diagnosis of CKD. Desired solutions will quantitatively assess risks and support active CKD diagnosis by primary care providers.
- Partners
- AstraZeneca
- Status
- Currently accepting（Due:2023.9.30）
Please contact us the below inquiry form
Early intervention for COPD
Chronic obstructive pulmonary disease (COPD) is one of the diseases, where we still see a high number of undiagnosed patients. We are seeking for ideas that may help potential patients recognize that they have COPD and start treatment with a specialist, preferably by direct activation of potential COPD patients with traceability function to confirm their visit to a specialist.
- Partners
- AstraZeneca
- Status
- Currently accepting（Due:2023.9.30）
Please contact us the below inquiry form
Remote home care after treatment
We are seeking for innovative remote home care monitoring tools or services to evaluate patient conditions after treatment. Desired solutions will need to be user-friendly for the elderly in home care setting, with highly accurate sensing technologies.
- Partners
- AstraZeneca
- Status
- Currently accepting（Due:2023.9.30）
Please contact us the below inquiry form
Closed Challenge Applications
Utilisation of digital biomarkers and digital therapeutics that can improve patient-centric outcomes in heart failure and renal disease
We are seeking innovative solutions accelerating innovative science.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Innovations in delivery of new modalities; peptides, oligos and antibodies across oncology, cardiovascular, renal and respiratory diseases
We are seeking innovative solutions accelerating innovative science.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Generating multi-omics data in specific patient cohorts including NASH, rare cardiovascular diseases and immunological conditions
We are seeking innovative solutions accelerating innovative science.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Identify sources of biological samples from diverse genetic backgrounds to enhance disease understanding
We are seeking innovative solutions accelerating innovative science.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Support the development of Regulatory T cell therapy for treatment of immune-mediated diseases
We are seeking innovative solutions accelerating innovative science.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Activate multidisciplinary teams to deliver optimal outcomes for cancer patients
We are seeking innovative solutions delivering growth and therapy area leadership.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Scale up integrated oncology patient care management platforms
We are seeking innovative solutions delivering growth and therapy area leadership.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Improve early detection of lung cancer
We are seeking innovative solutions delivering growth and therapy area leadership.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Drive systemic lupus erythematosus awareness and early patient identification
We are seeking innovative solutions delivering growth and therapy area leadership.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Transform severe asthma care and treatment
We are seeking innovative solutions delivering growth and therapy area leadership.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Improve early diagnosis of chronic kidney disease
We are seeking innovative solutions delivering growth and therapy area leadership.
- Partners
- AstraZeneca A.Catalyst Network
- Status
- Application deadline
Artificial Intelligence for Clinical Trial Readiness of Drug Candidates
AION Labs, Powered by BioMed X, Launches Second Global Call for Application:Artificial Intelligence for Clinical Trial Readiness of Drug Candidates
- Partners
- AION Labs, BioMed X
- Status
- Application deadline
Novel molecular insights into metabolic disease
We are seeking collaborators with novel molecular insight into the pathogenesis of metabolic disease that reverses hepatic, cardiovascular and/or renal complications.
- Partners
- AstraZeneca
- Status
- Application deadline
Gut microbiome modification to influence renal dysfunction
We are seeking novel methods that can modify the microbiome or its products to treat or prevent renal diseases. These may include (but are not limited to) clinical samples from interesting patient populations or innovative technologies and potential therapies.
- Partners
- AstraZeneca
- Status
- Application deadline
Molecular strategies to minimiseoff-target toxicities of antibody-drug conjugates (ADCs)
We are seeking proposals that may address the following areas: uptake in normal tissue, off target toxicity, delivery.
- Partners
- AstraZeneca
- Status
- Application deadline
Innovative vaccine technologies to enable the development of a universal HRV vaccine
We are seeking an innovative vaccine technology and/or antigen display approach that elicits a potent, broad and durable immune response to enable a universal HRV vaccine.
- Partners
- AstraZeneca
- Status
- Application deadline
Novel solutions for the non-invasive detection and monitoring of NASH
We are seeking novel solutions that enable the non-invasive diagnosis and monitoring of NASH disease progression/regression. The ideal solution would deliver impact in the near-medium term.
- Partners
- AstraZeneca
- Status
- Application deadline
Revitalizing Saga Prefecture through Beauty and Healthcare Investments
We are looking for domestic and foreign start-ups that aim to develop innovative products/services, under the three themes “Cosmetics”, “Beauty Devices/Services”, and “Healthcare”, that will revitalize Saga Prefecture, one of Asia’s leading beauty and healthcare industry clusters.
- Partners
- Saga Prefecture
- Agorize Japan
- Vertex Partners
- Status
- Application deadline
For inquiries
Interested in joining us?
Thank you for your interest. We will get in touch soon.